CareDx (NASDAQ: CDNA) planned Rule 144 sale of 29,636 shares common stock

Rhea-AI Filing Summary

A stockholder of CareDx (CDNA) has filed a notice of a planned sale of 29,636 shares of common stock under Rule 144. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on or around 01/15/2026 on the NASDAQ market, with an aggregate market value of $602,203.52 based on the price used in the notice.

The shares to be sold were acquired from the issuer as restricted stock units on 04/15/2025, in the same amount of 29,636 shares. The notice indicates that there were 51,432,639 shares of the issuer’s common stock outstanding, giving context for the size of the planned sale relative to the total share count.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	29636	602203.52	51432639	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2025	Restricted Stock Units	Issuer			29636	04/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CareDx (CDNA) shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 29,636 shares of CareDx common stock under Rule 144.

What is the aggregate market value of the CareDx (CDNA) shares to be sold?

The filing reports an aggregate market value of $602,203.52 for the 29,636 CareDx common shares to be sold.

When were the CareDx (CDNA) shares being sold acquired and in what form?

The 29,636 shares were acquired on 04/15/2025 as restricted stock units from the issuer.

On which exchange and through which broker will the CareDx (CDNA) shares be sold?

The planned sale is through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

What is the total number of CareDx (CDNA) shares outstanding referenced in the notice?

The notice states that 51,432,639 shares of CareDx common stock were outstanding.

What is the approximate date of the planned CareDx (CDNA) share sale?

The approximate date of sale listed in the notice is 01/15/2026.